Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Pressure BioSciences, Inc.    PBIO   US74112E1091

SummaryNewsCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201120122013201420152016
Sales--1,502,116,85-
Operating income (EBITDA)---3,25-3,09-1,35-
Operating profit (EBIT)---3,33-3,23-1,77-
Pre-Tax Profit (EBT)------
Net income----8,75-2,09-
EPS ( $)----0,57-0,10-
Dividend per Share ( $)------
Yield------
Announcement Date12/31/1969
07:00pm
12/31/1969
07:00pm
03/31/2014
06:00pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201120122013201420152016
Debt------
Finance------
Operating income (EBITDA)---3,25-3,09-1,35-
Leverage
(Debt/EBITDA)
------
Capital Expenditure--0,06---
Book Value Per Share (BVPS)------
Cash Flow per Share------
Announcement Date12/31/1969
07:00pm
12/31/1969
07:00pm
03/31/2014
06:00pm
---
Assessed data source :
© 2014 Thomson Reuters
Advertisement
Financial Ratios

Size 2014e 2015e
Capitalization 4,83 M$ -
Entreprise Value (EV) - 4,83 M$
Valuation 2014e 2015e
PER (Price / EPS)
Capitalization / Revenue 2,29x 0,70x
EV / Revenue - -
EV / EBITDA - -
Yield (DPS / Price) - -
Profitability 2014e 2015e
Operating Margin (EBIT / Sales) -153% -25,8%
operating Leverage (Delta EBIT / Delta Sales) 0,07x 0,20x
Net Margin (Net Profit / Revenue) -415% -30,5%
ROA (Net Profit / Asset) - -
ROE (Net Profit / Equities) - -
Rate of Dividend - -
Balance Sheet Analysis 2014e 2015e
CAPEX / Sales   - -
Cash Flow / Sales (Taux d'autofinancement) - -
Capital Intensity (Assets / Sales) - -
Financial Leverage (Net Debt / EBITDA) - -
EPS & Dividend
Dynamic quotes  
ON
| OFF